Okajima Wataru, Komatsu Shuhei, Ichikawa Daisuke, Kosuga Toshiyuki, Kubota Takeshi, Okamoto Kazuma, Konishi Hirotaka, Shiozaki Atsushi, Fujiwara Hitoshi, Otsuji Eigo
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
J Gastroenterol Hepatol. 2016 Sep;31(9):1566-71. doi: 10.1111/jgh.13306.
In gastric cancer, although at least 16 lymph nodes of retrieved lymph nodes (RLNs) are recommended for nodal staging in Japanese Classification of Gastric Carcinoma and TNM classifications, we wished to clarify their appropriateness.
A total of 1289 consecutive gastric cancer patients, who underwent gastrectomy between 1997 and 2011, were analyzed retrospectively.
(i) The patients were divided into two groups using a cut-off RLN number of 16 (RLN < 16 or RLN ≥ 16). There were significant differences in the survival rates of patients in pStage II (P < 0.0001) and III (P = 0.0009), but not those of patients in pStage I (P = 0.0627) and IV (P = 0.1553). (ii) In 498 consecutive patients in pStage II and III, compared with patients in the RLN ≥ 16 group, those in the RLN < 16 group had a significantly higher incidence of older age (P = 0.0004) and positive lymph node ratio (PLNR) (P < 0.0001). Univariate and multivariate analyses showed that an RLN number of less than 16 was an independent poor prognostic factor (P < 0.0001, HR 2.48 [95% CI: 1.60-3.70]). (iii) A cut-off RLN number of 16 could cause the stage migration effect in pStage II or III patients. A cut-off RLN number of 25 or more could eliminate the prognostic effect.
The RLN number may potentially affect the prognosis and the stage migration in pStage II or III gastric cancer patients. An RLN number of 25 or more could be sufficient for nodal staging.
在胃癌中,尽管日本胃癌分类和TNM分类推荐至少获取16枚送检淋巴结(RLNs)用于淋巴结分期,但我们希望阐明其合理性。
对1997年至2011年间连续接受胃切除术的1289例胃癌患者进行回顾性分析。
(i)根据RLN数量16将患者分为两组(RLN < 16或RLN ≥ 16)。pII期(P < 0.0001)和III期(P = 0.0009)患者的生存率存在显著差异,但pI期(P = 0.0627)和IV期(P = 0.1553)患者的生存率无显著差异。(ii)在498例连续的pII期和III期患者中,与RLN ≥ 16组患者相比,RLN < 16组患者年龄较大(P = 0.0004)和阳性淋巴结比率(PLNR)较高(P < 0.0001)的发生率显著更高。单因素和多因素分析显示,RLN数量少于16是一个独立的不良预后因素(P < 0.0001;风险比2.48 [95%置信区间:1.60 - 3.70])。(iii)RLN数量16可能会导致pII期或III期患者出现分期迁移效应。RLN数量25或更多可消除预后效应影响
RLN数量可能会影响pII期或III期胃癌患者的预后和分期迁移。RLN数量25或更多可能足以进行淋巴结分期。